In Germany, community acquired pneumonia is the most important infectious disease. Every year, 800,000 people contract the disease; and 50,000 die of it, making it the sixth most common cause of death. The number of people who are hospitalised due to pneumonia is still rising. It thus seems surprising that medical personnel and researchers know relatively little about this widespread disease, the pathogens that cause the disease, their resistance to antibiotics and the progression of the disease. A new foundation based in Ulm is hoping to contribute to a better understanding of this unpleasant disease and to improve the therapy to combat it.